BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $78,000 | -2.5% | 22,708 | -19.3% | 0.00% | – |
Q3 2019 | $80,000 | -39.8% | 28,128 | -19.7% | 0.00% | – |
Q2 2019 | $133,000 | -53.3% | 35,018 | 0.0% | 0.00% | – |
Q1 2019 | $285,000 | -83.2% | 35,018 | -82.7% | 0.00% | – |
Q1 2017 | $1,700,000 | +133.8% | 202,317 | -21.0% | 0.00% | – |
Q2 2016 | $727,000 | -82.8% | 256,120 | -82.9% | 0.00% | -100.0% |
Q1 2016 | $4,236,000 | -94.5% | 1,496,859 | -80.0% | 0.00% | -95.0% |
Q4 2015 | $77,096,000 | -9.9% | 7,470,439 | -0.4% | 0.02% | -16.7% |
Q3 2015 | $85,523,000 | -18.0% | 7,501,936 | +7.5% | 0.02% | -11.1% |
Q2 2015 | $104,235,000 | +64.4% | 6,981,571 | -0.6% | 0.03% | +68.8% |
Q1 2015 | $63,393,000 | -29.4% | 7,020,283 | -5.0% | 0.02% | -33.3% |
Q4 2014 | $89,854,000 | +56.8% | 7,389,273 | +26.1% | 0.02% | +50.0% |
Q3 2014 | $57,305,000 | -16.0% | 5,859,426 | +9.5% | 0.02% | -11.1% |
Q2 2014 | $68,204,000 | +60.4% | 5,349,345 | +33.1% | 0.02% | +50.0% |
Q1 2014 | $42,529,000 | +16.8% | 4,019,761 | -16.1% | 0.01% | +20.0% |
Q4 2013 | $36,413,000 | +90.1% | 4,791,230 | +82.1% | 0.01% | +66.7% |
Q3 2013 | $19,158,000 | – | 2,631,590 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |